Immunohistochemistry
In order to determine activation of mTOR and interconnected pathways, all available biopsies (N=33) were stained for phospho-S6 (Phospho-S6 Ribosomal (Ser240/244) by Cell Signaling Technologies, Danvers MA, USA) and phospho-ERK (Phospho-P44/42 (Erk1/2) (Thr202/Tyr204) by Cell Signaling Technologies, Danvers MA, USA). Phospho-S6 is a marker for activation of mTOR, pERK is a marker for MAPK pathway activation. All samples were converted to FFPE, immunohistochemistry was performed on a BenchMark Ultra autostainer (Ventana Medical Systems, Tuscon AZ, USA). Briefly, paraffin sections were cut at 3 um, heated at 75°C for 28 minutes and deparaffinized in the instrument with EZ prep solution (Ventana Medical Systems, Tuscon AZ, USA). Heat-induced antigen retrieval was carried out using Cell Conditioning 1 (Ventana Medical Systems, Tuscon AZ, USA) for 32 minutes at 95 0 C (Phospho-S6 Ribosomal (Ser240/244)), or 64 minutes at 95 0 C (Phospho-P44/42 (Erk1/2) (Thr202/Tyr204)). Phospho-P44/42 (Erk1/2) (Thr202/Tyr204) was detected using clone D13.14.4E (1/400 dilution, 1 hour 36°C, Cell Signaling Technologies, Danvers MA, USA), Phospho-S6 Ribosomal (Ser240/244) was detected using clone D68F8 (1/1000 dilution, 32 minutes at 36°C, Cell Signaling Technologies, Danvers MA, USA). Bound antibody was detected using the UltraView DAB Detection kit (Phospho-P44/42 (Erk1/2) (Thr202/ Tyr204)) or the OptiView DAB Detection Kit (Phospho-S6 Ribosomal (Ser240/244)) (Ventana Medical Systems, Tuscon AZ, USA). Slides were counterstained with Hematoxylin II and Bluing Reagent (Ventana Medical Systems, Tuscon AZ, USA). Slides were scored for intensity (0-3) and percentage of positive tumor cells by a pathologist blinded for treatment outcome.
